ArticleJournal for immunotherapy of cancer2022
Correction: Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64).
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.